Shot in the arm or a shot in the dark? Complacency fears over Covid-19 vaccine equity market boost
Market rally too premature, experts warn
Value stocks fared best throughout the week following news of Pfizer's vaccine breakthrough
The equity market rally sparked by news of Pfizer's Covid-19 vaccine breakthrough last week may have been "over the top", with significant hurdles still ahead for investors, despite growing confidence among value-focused fund groups that their investment style may finally be about to break its losing streak.
Equity markets globally climbed higher on reports that Pfizer's vaccine could be imminently available, as investors saw hope the coronavirus-inspired economic slowdown could soon be nearing its end...
More on Global
Back to Top
